PT  - JOURNAL ARTICLE
ED  - ,
TI  - Correction: High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma
AID  - 10.1136/jitc-2023-008325corr1
DP  - 2024 Mar 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e008325corr1
VI  - 12
IP  - 3
4099  - http://jitc.bmj.com/content/12/3/e008325corr1.short
4100  - http://jitc.bmj.com/content/12/3/e008325corr1.full
SO  - J Immunother Cancer2024 Mar 01; 12